CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,432,082
- in 7 filings
Net −$19,432,082. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-22 | Krempa David Chief Business Officer | Sale | −9,315 | $33.88 | $316K | 25,768 |
| 2026-05-22 | Krempa David Chief Business Officer | Sale | −519 | $35.00 | $18K | 25,249 |
| 2026-05-22 | Krempa David Chief Business Officer | Option exercise · Employee Stock Option | −30,591 | 125,609 | ||
| 2026-04-21 | RIEDEL NORBERT G Director | Option exercise | +12,500 | $7.31 | $91K | 47,500 |
| 2026-04-21 | RIEDEL NORBERT G Director | Option exercise | +19,655 | $8.61 | $169K | 67,155 |
| 2026-04-21 | RIEDEL NORBERT G Director | Option exercise · Employee Stock Option (Right to Buy) | −12,500 | 0 | ||
| 2026-04-21 | RIEDEL NORBERT G Director | Option exercise · Employee Stock Option (Right to Buy) | −19,655 | 0 | ||
| 2026-02-03 | RIEDEL NORBERT G Director | Option exercise | +30,000 | $4.42 | $133K | 35,000 |
| 2026-02-03 | RIEDEL NORBERT G Director | Option exercise · Employee Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2026-01-14 | Krempa David Chief Business Officer | Shares withheld for taxes | −1,942 | $15.62 | $30K | 630,238 |
| 2026-01-14 | Gruber James R. Chief Financial Officer | Shares withheld for taxes | −2,293 | $15.47 | $35K | 213,420 |
| 2026-01-12 | RIEDEL NORBERT G Director | Grant or award · Employee Stock Option (Right to Buy) | +12,196 | 286,496 | ||
| 2026-01-12 | RIEDEL NORBERT G Director | Grant or award · Restricted Stock Units | +7,757 | 294,253 | ||
| 2026-01-12 | Adams Jennifer McKie Director | Grant or award · Employee Stock Option (Right to Buy) | +12,196 | 170,329 | ||
| 2026-01-12 | Adams Jennifer McKie Director | Grant or award · Restricted Stock Units | +7,757 | 178,086 | ||
| 2026-01-12 | CASAMENTO CHARLES J Director | Grant or award · Employee Stock Option (Right to Buy) | +12,196 | 295,171 | ||
| 2026-01-12 | CASAMENTO CHARLES J Director | Grant or award · Restricted Stock Units | +7,757 | 302,928 | ||
| 2026-01-12 | MAIER PAUL V Director | Grant or award · Employee Stock Option (Right to Buy) | +12,196 | 286,496 | ||
| 2026-01-12 | MAIER PAUL V Director | Grant or award · Restricted Stock Units | +7,757 | 294,253 | ||
| 2026-01-12 | Erdogan-Trinkaus Ipek Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +40,655 | 123,878 |
Page 5 of 13 · 249 trades